U.S. Markets closed

LeMaitre Vascular Inc (LMAT) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

LeMaitre Vascular Inc (LMAT) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons. LeMaitre Vascular Inc has a market cap of $586.100 million; its shares were traded at around $29.93 with a P/E ratio of 26.48 and P/S ratio of 5.86. The dividend yield of LeMaitre Vascular Inc stocks is 0.93%. LeMaitre Vascular Inc had annual average EBITDA growth of 27.70% over the past five years.


For the last quarter LeMaitre Vascular Inc reported a revenue of $28.4 million, compared with the revenue of $26.15 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $105.6 million, an increase of 4.7% from last year. For the last five years LeMaitre Vascular Inc had an average revenue growth rate of 11% a year.

The reported diluted earnings per share was $1.13 for the year, an increase of 31.4% from previous year. Over the last five years LeMaitre Vascular Inc had an EPS growth rate of 44.5% a year. The LeMaitre Vascular Inc had a decent operating margin of 19.64%, compared with the operating margin of 20.92% a year before. The 10-year historical median operating margin of LeMaitre Vascular Inc is 9.50%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, LeMaitre Vascular Inc has the cash and cash equivalents of $26.3 million, compared with $19.1 million in the previous year. The company had no long term debt. LeMaitre Vascular Inc has a financial strength rank of 9 (out of 10).

At the current stock price of $29.93, LeMaitre Vascular Inc is traded at 211.1% premium to its historical median P/S valuation band of $9.62. The P/S ratio of the stock is 5.86, while the historical median P/S ratio is 1.89. The stock lost 19.1% during the past 12 months.

For the complete 20-year historical financial data of LMAT, click here.

This article first appeared on GuruFocus.